‘The French will soon have to stay indoors for half a day’ | NOW

Pharmaceutical Johnson & Johnson expects to have the vaccine ready in March
US pharmaceutical company Johnson & Johnson (J&J) expects its corona vaccine to be available in March. The company expects to be able to share data on effectiveness this month, or no later than early February. That’s what the head of the science division, Paul Stoffels, told the news agency Reuters.

The J&J vaccine was developed by subsidiary Janssen in Leiden. Stoffels said the goal is to have one billion vaccines delivered by the end of this year. Unlike other corona vaccines, the J&J drug consists of a single dose. For the vaccines from Pfizer / BioNTech and Moderna, two doses must be injected, with several weeks between injections.

Wrote earlier on Wednesday The New York Times that J&J is facing production delays. As a result, the company may not be able to meet its promised deliveries to the US government this spring. In April, the pharmaceutical company is expected to deliver more than 60 million doses of its corona vaccine to the US government.

This is still dependent on approvals. J&J could also request approval from the European medicine agency EMA in February, EU Commissioner Stella Kyriakides (Public Health) said. The European Commission has ordered 200 million doses of the vaccine, with an option for an additional 200 million.

J & J’s drug is produced in the United States, Europe, India and South Africa. According to Stoffels, it is still a bit too early to talk about production numbers in the coming months.


Leave a Reply

Your email address will not be published. Required fields are marked *